Thought I’d mention that Safeguard Scientifics is releasing its financial results for the second quarter ended June 30, 2010 prior to market open this Thursday,…
Posted by
Back in February, I wrote a blog post summarizing my observations “from the road,” where we met with brokers, analysts and portfolio managers and shared…
Posted by
At Safeguard Scientifics, we often talk about the importance of our partnerships with the life sciences and technology companies in which we deploy capital. There’s…
Posted by
This morning, we announced that aggregate partner company revenue for the first quarter 2010 was up 46 percent from $58.4 million for the same partner…
Posted by
Thought I’d mention that Safeguard Scientifics is releasing its financial results for the first quarter ended March 31, 2010 prior to market open on Thursday,…
Posted by
Our partner company, Avid Radiopharmaceuticals, announced positive interim results from the Phase III clinical trial of its amyloid imaging agent Florbetapir F18 for early diagnosis…
Posted by
Since coming to Safeguard Scientifics nearly five years ago, our management team created a game plan to transition our partner companies from a group of…
Posted by
We’ve all had one of those weeks when you need to read the newspaper to remember what city you are in and what day it…
Posted by
We have spoken frequently with shareholders about our objective to investigate opportunities to restructure, refinance or repay some of our existing 2024 debentures on or…
Posted by
